JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Home
Signaling Pathways

Signaling Pathways

A2606 Epoxomicin
25 Citation

Summary: Proteasome inhibitor

≥27.73 mg/mL
A2585 MG-132
26 Citation

Target: Proteasome

Summary: Proteasome inhibitor, Cell permeable, reversible

≥23.78 mg/mL
A4011 ONX-0914 (PR-957)
6 Citation

Target: Proteasome

Summary: Immunoproteasome inhibitor,potent and selective

≥29.03 mg/mL
A4010 Salinosporamide A (NPI-0052, Marizomib)

Target: Proteasome

Summary: 20S proteasome inhibitor

Soluble in DMSO
A2612 MG-115
1 Citation

Target: Proteasome

Summary: Potent reversible proteasome inhibitor

≥23.08 mg/mL
A2614 Bortezomib (PS-341)
24 Citation

Target: Proteasome

Summary: Proteasome Inhibitor

insoluble in EtOH; insoluble in H2O; ≥19.21 mg/mL
A1900 PSI

Summary: Proteasome inhibitor

≥30.6 mg/mL
A1903 E 64d
4 Citation

Summary: Cysteine protease inhibitor

insoluble in H2O; ≥17.12 mg/mL
A4393 Paclitaxel (Taxol)
4 Citation

Target: Microtubules/Tubulins

Summary: Antineoplastic agent

≥85.6 mg/mL
A1933 Carfilzomib (PR-171)
10 Citation

Target: Proteasome

Summary: Proteasome inhibitor, epoxomicin analog

≥35.99 mg/mL